xpro1595
·Code: XPro1595
xpro1595: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Inmune Bio, Inc. (INMB) | Phase 2 |
Clinical Trials (1)
An Open Label Extension of XPro1595 in Patients With Alzheimer's Disease That Have Completed a Phase 1 or Phase 2 Study With XPro1595
Frequently asked questions
Who is developing xpro1595?
xpro1595 is being developed by Inmune Bio, Inc..
How many clinical trials involve xpro1595?
BioSniper tracks 1 clinical trial involving xpro1595.
Get deeper analysis on xpro1595
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis